EBMT 36th (2010)

Title Content type
Preliminary results of a phase II trial of clofarabine with busulfan followed by allogeneic related or unrelated donor transplantation for the treatment of haematologic malignancies (click for details)
Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease (click for details)
Impact of previous fungal infection on the outcome of allogeneic haematopoietic stem cell transplantation: after introducing new antifungal agents (click for details)
Tregs combined with mature donor T-cells hasten immune reconstitution without triggering GvHD in HLA haploidentical transplantation (click for details)
Ef64257; cacy and safety of caspofungin in paediatric allogeneic haematopoietic stem cell transplantation: a single-centre study (click for details)
Systemically administered MSCs following BMT home to in64258; amed tissues including CNS (click for details)
Epidemiology of invasive fungal diseases in haematopoietic stem cell transplant recipients: preliminary analysis of a multicentre, prospective, observational study from Italy (click for details)
Caspofungin plus posaconazol as salvage therapy of invasive fungal infections in haematopoietic cell transplantation (click for details)
Allogeneic haematopoietic stem cell transplantation for relapsed/refractory acute leukaemia – a single-centre experience (click for details)
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and haematopoietic stem cell transplantation (click for details)

Pages

Subscribe to EBMT 36th (2010)